Tafasitamab and lenalidomide are likely to be approved with R-CHOP for frontline DLBCL, but with bispecific antibodies on the horizon, the role of the combination is uncertain.

The largest randomized trial of its kind to date found noninferior survival and better arm morbidity among patients with breast cancer who did not undergo completion axillary lymph node dissection.

Data from the long-running HOME study links higher exposure to certain polyfluoroalkyl substances ‘forever chemicals’ with ...

A higher intake of several food colouring additives is associated with an increased risk of developing type 2 diabetes, an ...

Time-restricted eating alters the gut microbiota and serum metabolite profiles in young adults with overweight or obesity, with changes linked to weight loss and improved cardiometabolic health.

From narrow volume windows to SGLT2 inhibitors and emerging devices, Drs Kevin Alexander and Sarah Cuddy discuss heart ...

Endovascular thrombectomy with medical management improves functional independence vs medical management alone in stroke due ...

She’d diagnosed rheumatoid arthritis dozens of times but dismissed her own symptoms and fought her eventual diagnosis. Today ...

Experts skipped the cicada variant BA.3.2 and last year’s LP.8.1 vaccine strain and recommended monovalent XFG option.

A French study shows that kidney biopsy during early pregnancy appears safe — with only one patient with serious bleeding ...

Backed by 26 ministries and GRADE evidence, PAHO's new clinical pathway could accelerate access to SGLT2 inhibitors and ...

Emerging data suggest Western dietary patterns may promote inflammatory gut changes, whereas traditional diets appear linked to more favorable metabolic effects.